125 related articles for article (PubMed ID: 7053087)
21. Sugar-ring analogs of daunorubicin: 3'-epidaunorubicin, 3'-hydroxy-3',5'-diepidaunorubicin and 3',6'-dihydroxy-3',5'-diepidaunorubicin.
Cheung TM; Horton D; Priebe W; Turner WR; Weckerle W
J Antibiot (Tokyo); 1985 May; 38(5):683-6. PubMed ID: 4019314
[No Abstract] [Full Text] [Related]
22. Pharmacokinetic, toxicologic, and chemotherapeutic properties of detorubicin in mice: a comparative study with daunorubicin and adriamycin.
Deprez-de Campeneere D; Baurain R; Trouet A
Cancer Treat Rep; 1979 May; 63(5):861-7. PubMed ID: 455327
[TBL] [Abstract][Full Text] [Related]
23. Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin.
Mosher CW; Wu HY; Fujiwara AN; Acton EM
J Med Chem; 1982 Jan; 25(1):18-24. PubMed ID: 7086816
[TBL] [Abstract][Full Text] [Related]
24. Tetrahydropyranyl derivatives of daunomycin and adriamycin.
Umezawa H; Takahashi Y; Kinoshita M; Naganawa H; Masuda T; Ishizuka M; Tatsuta K; Takeuchi T
J Antibiot (Tokyo); 1979 Oct; 32(10):1082-4. PubMed ID: 528373
[No Abstract] [Full Text] [Related]
25. 4-Demethoxy-4-hydroxydaunorubicin 6-methyl ether and 11-methyl ether, two active isomers of daunorubicin.
Masi P; Suarato A; Giardino P; Iraci G; Bernardi L; Arcamone F
Farmaco Sci; 1980 May; 35(5):347-56. PubMed ID: 7450036
[TBL] [Abstract][Full Text] [Related]
26. New anthracycline glycosides: 4-O-demethyl-11-deoxydoxorubicin and analogues from Streptomyces peucetius var. aureus.
Cassinelli G; Rivola G; Ruggieri D; Arcamone F; Grein A; Merli S; Spalla C; Casazza AM; Di Marco A; Pratesi G
J Antibiot (Tokyo); 1982 Feb; 35(2):176-83. PubMed ID: 6951826
[TBL] [Abstract][Full Text] [Related]
27. New hydroxybenanomicins produced by Actinomadura.
Kondo S; Gomi S; Uotani K; Miyakawa S; Inouye S; Ikeda D; Takeuchi T
Drugs Exp Clin Res; 1992; 18(6):217-24. PubMed ID: 1478160
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic effects of the lysosomotropic agents DNA-ellipticine, DNA-daunorubicin, and DNA-ellipticine:daunorubicin on L1210 leukemia cells.
Sorace RA; Sheid B
Cancer Treat Rep; 1979 Jan; 63(1):43-51. PubMed ID: 421232
[No Abstract] [Full Text] [Related]
29. Neothramycins A and B, new antitumor antibiotics.
Takeuchi T; Miyamoto T; Ishizuka M; Naganawa H; Kondo S
J Antibiot (Tokyo); 1976 Jan; 29(1):93-6. PubMed ID: 931797
[No Abstract] [Full Text] [Related]
30. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
[No Abstract] [Full Text] [Related]
31. Glidobactins A, B and C, new antitumor antibiotics. I. Production, isolation, chemical properties and biological activity.
Oka M; Nishiyama Y; Ohta S; Kamei H; Konishi M; Miyaki T; Oki T; Kawaguchi H
J Antibiot (Tokyo); 1988 Oct; 41(10):1331-7. PubMed ID: 3142840
[TBL] [Abstract][Full Text] [Related]
32. Preparation and biological evaluation of 4-O-demethyldaunorubicin (carminomycin I) and of its 13-dihydro derivative.
Cassinelli G; Grein A; Masi P; Suarato A; Bernardi L; Arcamone F; Di Marco A; Casazza AM; Pratesi G; Soranzo C
J Antibiot (Tokyo); 1978 Mar; 31(3):178-84. PubMed ID: 649513
[TBL] [Abstract][Full Text] [Related]
33. Microbial conversion of epsilon-pyrromycinone and epsilon-isorhodomycinone to 1-hydroxy-13-dihydrodaunomcyin and N-formyl-1-hydroxy-13-dihydrodaunomycin and their bioactivities.
Yoshimoto A; Matsuzawa Y; Oki T; Naganawa H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Oct; 33(10):1150-7. PubMed ID: 7451366
[TBL] [Abstract][Full Text] [Related]
34. Isolation and characterization of a new antitumor antibiotic OS-3256-B from Streptomyces candidus var. azaticus.
Satoh K; Komiyama K; Kitao C; Iwai Y; Atsumi K
J Antibiot (Tokyo); 1974 Aug; 27(8):620-5. PubMed ID: 4474156
[No Abstract] [Full Text] [Related]
35. WF-3405, a novel antitumor antibiotic. Taxonomy, isolation, structure elucidation and biological properties.
Kiyoto S; Murai H; Tsurumi Y; Terano H; Kohsaka M; Takase S; Uchida I; Hashimoto M; Aoki H; Imanaka H
J Antibiot (Tokyo); 1987 Mar; 40(3):290-5. PubMed ID: 3570981
[TBL] [Abstract][Full Text] [Related]
36. Comparative biochemical studies of adriamycin and daunomycin in leukemic cells.
Wang JJ; Chervinsky DS; Rosen JM
Cancer Res; 1972 Mar; 32(3):511-5. PubMed ID: 5061305
[No Abstract] [Full Text] [Related]
37. [Models of preclinical studies of anthracyclines].
Fizames C
Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
[TBL] [Abstract][Full Text] [Related]
38. A new antitumor antibiotic, carminomycin (NSC-180024).
Gause GF; Brazhnikova MG; Shorin VA
Cancer Chemother Rep; 1974; 58(2):255-6. PubMed ID: 4830498
[No Abstract] [Full Text] [Related]
39. Synthetic anthracyclines: regiospecific total synthesis of D-ring thiophene analogues of daunomycin.
Kita Y; Kirihara M; Sekihachi J; Okunaka R; Sasho M; Mohri S; Honda T; Akai S; Tamura Y; Shimooka K
Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):1836-43. PubMed ID: 2268891
[TBL] [Abstract][Full Text] [Related]
40. New antitumor antibiotics aclacinomycins A and B.
Oki T; Matsuzawa Y; Yoshimoto A; Numata K; Kitamura I
J Antibiot (Tokyo); 1975 Oct; 28(10):830-4. PubMed ID: 1184473
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
